Published on 4 Sep 2023 on Zacks via Yahoo Finance
SCYNEXIS’ SCYX shares have surged 133.6% year to date against the industry's 1.9% decline.
Zacks Investment Research
Image Source: Zacks Investment Research
Start tracking your investments with Statfolio
Overview of Recent Transaction Federated Hermes, Inc., a prominent institutional investor, recent...
Long term investing is the way to go, but that doesn't mean you should hold every stock forever. ...
We're definitely into long term investing, but some companies are simply bad investments over any...
SCYNEXIS' (NASDAQ:SCYX) stock is up by a considerable 18% over the past three months. As most wou...
SCYNEXIS’ SCYX shares have surged 133.6% year to date against the industry's 1.9% decline. <img a...
Avalo Therapeutics, Inc. (AVTX) came out with a quarterly loss of $0.59 per share versus the Zack...
Scynexis (SCYX) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Esti...
Key Insights The considerable ownership by individual investors in SCYNEXIS indicates that they c...
SCYNEXIS, Inc. (NASDAQ:SCYX) is possibly approaching a major achievement in its business, so we w...
Shares of Scynexis SCYX surged almost 76% on Mar 30, after it entered an exclusive license agreem...